PHE women’s reproductive health programme 2020 to 2021
Progress update on the PHE reproductive health programme, including a new return on investment tool and the next steps for 2021 to 2022.
Documents
Details
Use these documents and tools to understand more about the work the Public Health England (PHE) reproductive health programme has been carrying out during 2020 and 2021 – and how this integrates with the upcoming women’s and sexual and reproductive health strategies. Links to new tools, publications and examples of best practice can also be used as a reference point for colleagues across the healthcare system, to inform prioritisation and planning.
‘Measuring population reproductive health: developing a new indicator set’ describes a new suite of reproductive health indicators developed via a consensus process with a steering group of experts in 2020.
‘Extending PHE’s contraception return on investment tool: maternity and primary care settings’ outlines a new return on investment (ROI) model for contraception in maternity and the provision of long-acting reversible contraceptives (LARC) in primary care, building on the existing contraception ROI tool published in 2018.
The accompanying spreadsheet tool can be adjusted by users to model the costs and benefits of existing and future scenarios in a local, regional, or national context. A strong ROI is demonstrated in both settings. For every £1 invested in the maternity intervention, there is a saving of £32 for the public sector. Investment in the provision of additional LARC by GPs has even greater potential cost savings, with an ROI of £48 for every £1 invested.